Management of PAH in Adults with Congenital Heart Disease: Impact and Dilemmas

Guest editor Richard Krasuski, MD, convened a group of experts by telephone on January 17, 2013, to discuss current trends in diagnosis and treatment of pulmonary hypertension among patients with congenital heart disease. Joining the call were Professor Maurice Beghetti, Head of Pediatric Subspecialties, Division Head of Pediatric Cardiology Unit, Children's University Hospital, Geneva, Switzerland; Curt Daniels, MD, Director, Adolescent and Adult Congenital Heart Disease Program Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio; Wayne J. Franklin, MD, Texas Children's Hospital, Houston; and Michael J. Landzberg, MD, Associate Director, Adult Pulmonary Hypertension Program and Director, Boston Adult Congenital Heart Program, Boston Children's Hospital.